Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlycoMimetics (GLYC)
NASDAQ:GLYC
GlycoMimetics (GLYC) Stock Price & Analysis
803 Followers
GLYC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.11 - $3.53
Previous Close$2.26
Volume598.97K
Average Volume (3M)393.55K
Market Cap
$145.34M
Enterprise Value$104.34M
Total Cash (Recent Filing)$41.80M
Total Debt (Recent Filing)$808.40K
Price to Earnings (P/E)-3.9
Beta2.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding64,450,385
10 Day Avg. Volume592,460
30 Day Avg. Volume393,553
Standard Deviation0.35
R-Squared0.11
Alpha-0.00711
Financial Highlights & Ratios
Price to Book (P/B)4.03
Price to Sales (P/S)15468.09
Price to Cash Flow (P/CF)-5.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.43K
Enterprise Value/Gross Profit10.43K
Enterprise Value/Ebitda-2.91
Forecast
1Y Price Target
$7.00Price Target Upside225.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
GlycoMimetics News
PremiumCompany Announcements
GlycoMimetics Provides Update with Investor Presentation
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GLYC FAQ
What was GlycoMimetics’s price range in the past 12 months?
GlycoMimetics lowest stock price was $1.11 and its highest was $3.53 in the past 12 months.
What is GlycoMimetics’s market cap?
Currently, no data Available
When is GlycoMimetics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GlycoMimetics’s earnings last quarter?
Currently, no data Available
Is GlycoMimetics overvalued?
According to Wall Street analysts GlycoMimetics’s price is currently Undervalued.
Does GlycoMimetics pay dividends?
GlycoMimetics does not currently pay dividends.
What is GlycoMimetics’s EPS estimate?
GlycoMimetics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlycoMimetics have?
GlycoMimetics has 64,450,386 shares outstanding.
What happened to GlycoMimetics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GlycoMimetics?
Currently, no hedge funds are holding shares in GLYC
---
GlycoMimetics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.00 (225.58% Upside)
$7.00 (225.58% Upside)
Blogger Sentiment
Bullish
GLYC Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▲ 17.1%
Last 30 Days ▲ 17.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.40%
12-Months-Change
Fundamentals
Return on Equity
-90.72%
Trailing 12-Months
Asset Growth
-12.53%
Trailing 12-Months
Company Description
GlycoMimetics
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
---
GLYC Stock 12 Months Forecast
Average Price Target
$7.00
▲(225.58% Upside)
Technical Analysis
Best Analysts Covering GLYC
1 Year
1 Year Success Rate
12/20 ratings generated profit
1 Year Average Return
+24.77%
reiterated a buy rating 22 days ago
Copying Edward White's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +24.77% per trade.
---